(Note: Thank you for supporting businesses like the one presenting a sponsored message below and working with them through the links below which benefits Gateway Pundit. We appreciate your support!)
Greed in medicine isn’t new but since the COVID-19 pandemic, more and more Americans are waking up to the sad reality that much of the medical establishment is more interested in the bottom line than the health outcomes of patients.
It should come as no surprise then, that big pharma and the medical establishment have absolutely no interest in pursuing low-cost treatments, especially when it comes to diseases such as cancer that are a cash cow for big pharma.
Fortunately, we have a growing number of medical professionals who are committed to restoring faith in our healthcare system and making affordable and effective treatments available to all Americans.
Dr. William Makis, one of the most well-known critics of the failed response to the COVID-19 pandemic, has been an enthusiastic advocate for the use of Ivermectin and mebendazole in treating a wide array of cancers.
Dr. Makis listed 20 studies that show the potential for Ivermectin in fighting cancer:
Here are recent studies on IVERMECTIN use in certain types of cancer:
BLADDER CANCER– (2024 Fan et al) – Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage
LUNG CANCER– (2024 Man-Yuan Li et al) – Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells
GLIOMA– (2024 Xing Hu et al) – Ivermectin as a potential therapeutic strategy for glioma
MULTIPLE MYELOMA– (2024 Yang Song et al) – Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma
OVARIAN CANCER– (2023 Jawad et al) – Ivermectin augments the anti-cancer activity of pitavastatin in ovarian cancer cells
PROSTATE CANCER –(2022 Lu et al) – Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer
COLON CANCER– (2022, Alghamdi et al) – Efficacy of ivermectin against colon cancer induced by dimethylhydrazine in male wistar rats
PANCREATIC CANCER– (2022 Lee et al) – Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells viamitochondrial dysfunction
MELANOMA– (2022 Zhang et al) – Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis
CERVICAL CANCER– (2022, Qabbus et al) – Ivermectin-induced cell death of cervical cancer cells in vitro a consequence of precipitate formation in culture media
HEPATOCELLULAR CARCINOMA– (2022 Lu et al) – Ivermectin synergizes sorafenib in hepatocellular carcinoma via targeting multiple oncogenic pathways
OSTEOSARCOMA– (2022 Hu et al) – Repurposing Ivermectin to augment chemotherapy’s efficacy in osteosarcoma
GASTRIC CANCER– (2021 Rabben et al) – Computational drug repositioning and experimental validation of ivermectin in treatment of gastric cancer
LEUKEMIA– (2020, de Castro et al) – Continuous high-dose ivermectin appears to be safe in patients with acute myelogenous leukemia and could inform clinical repurposing for COVID-19 infection
ESOPHAGEAL SCC– (2020, Chen et al) – Ivermectin suppresses tumour growth and metastasis through degradation of PAK1 in oesophageal squamous cell carcinoma
CHOLANGIOCARCINOMA– (2019 Intyuod et al) – Anti-parasitic drug ivermectin exhibits potent anticancer activity against gemcitabine-resistant cholangiocarcinoma in vitro
BREAST CANCER STEM CELLS –(2018 Dominguez-Gomez et al) – Ivermectin as an inhibitor of cancer stem-like cells
CML (CHRONIC MYELOID LEUKEMIA)– (2018 Wang et al) – Antibiotic ivermectin selectively induces apoptosis in chronic myeloid leukemia through inducing mitochondrial dysfunction and oxidative stress
RENAL CELL CARCINOMA– (2017 Zhu et al) – Antibiotic ivermectin preferentially targets renal cancer through inducing mitochondrial dysfunction and oxidative damage
GLIOBLASTOMA– (2016 Liu et al) – Anthelmintic drug ivermectin inhibits angiogenesis, growth and survival of glioblastoma through inducing mitochondrial dysfunction and oxidative stress
Dr. Makis makes it clear that he believes Ivermectin could be a valuable tool in the battle against cancer and explains why the medical establishment is in no hurry to explore Ivermectin’s potential:
IVERMECTIN has proven anti-cancer activity against some 20 cancer types, although these are pre-clinical studies. We will never see clinical studies because Ivermectin is off patent and cheap.Merck, which used to have a patent on Ivermectin, has partnered with Moderna on mRNA Cancer Vaccines, estimated to cost 400,000 GBP per treatment.Ivermectin studies on mice include: Breast cancer, Colon cancer, glioblastoma, glioma and leukemia.I have not seen IVERMECTIN studies on Lymphoma, Testicular Cancer, Sarcomas.IVERMECTIN acts on Cancer mainly by inhibiting signaling pathways involved in cancer proliferation (Akt, Wnt, mTOR) and by inhibiting CANCER STEM CELLS.
Dr. Makis is the only trusted medical professional talking about the potential of Ivermectin. According to the McCullough Foundation a new study confirms the early returns on Ivermectin are positive:
The study titled “A Review of Ivermectin Use in Cancer Patients: Is it Time to Repurpose the Ivermectin in Cancer Treatment?” was just published in the journal Acta Poloniae Pharmaceutica – Drug Research…Based on the most comprehensive systematic review of ivermectin use in cancer patients to date, ivermectin appears to be safe—even in individuals undergoing active chemotherapy. Its broad range of anticancer mechanisms demonstrated in preclinical models, combined with anecdotal reports of cancer-related improvements, support its candidacy for repurposing as an oncologic therapy. Well-designed, large-scale clinical trials should be launched as soon as possible to properly assess ivermectin’s potential against cancer.
Indeed, ivermectin in concert with mebendazole has shown even more promise in treating a wide variety of cancers.
Mebendazole, an anti-parasitic like ivermectin, has been prescribed for 100 years to help eradicate parasites – which over 60 million Americans have inside their body today, according to the CDC.
Safe, Effective and Affordable!
If you feel off, a parasite cleanse may help you regain your health. There is no better cleanse than pure lab-tested Ivermectin + Mebendazole, compounded into a single capsule by The Wellness Company.
Ivermectin and Mebendazole combine to effectively treat parasitic infections.
90 Oral Capsules, each containing 25mg Ivermectin + 250mg Mebendazole, a clinically effective dose.
The Gold Standardof safety and efficacy; the only medication of its kind prescribed by a licensed doctor and compounded by a 50-state licensed pharmacy.
Medication You Can Trust from a Trusted Source in the USA
The medical experts at The Wellness Company – like Dr. Peter McCullough and Dr. Kelly Victory – were leaders in the efforts to provide the public with accurate medical information during COVID. These experts have repeatedly shown that they prioritized the health and welfare of their patients over the bottom line of the big pharmaceutical companies.
Now, The Wellness Company is the only company in the world to prescribe pure compounded Ivermectin + Mebendazole from a 50-state licensed pharmacy, in a high-dose 90-day supply.
The Wellness Company’s Ivermectin + Mebendazole Parasite Cleanse is in extreme demand, selling out 3 times – prompting The Wellness Company to build a stockpile of medication to serve customers through any potential supply chain disruptions.
With the threat of tariffs restricting international trade, many people have turned to shady overseas sources of medication or unlicensed pharmacies. The Wellness Company proudly remains the only legitimate producer of this compounded formula in the US.
Head over to The Wellness Company today to order a 90-day supply of the ultimate parasite cleanse – Ivermectin + Mebendazole. Simply fill out the 2-minute intake questionnaire after checkout to complete your prescription request.
What people are saying about The Wellness Company’s Ivermectin + Mebendazole:
Gastrointestinal difficulties disappeared after 24 hours. On day three the so-called “unexplained joint and muscle pain” that was diagnosed as part of Persian Gulf illness has lessened. On day four the gastric reflux that has prevented me from drinking coffee or eating fatty foods has all but disappeared . . . I could go on with difficulties that I suspect have improved with the Parasite Cleanse but these items I mentioned are directly the effect of the Ivermectin and Mebendazole. – Stephen
I am grateful to have a medicine as potentially beneficial as ivermectin and mebendazole, but the most important thing for me is the faith I have in Dr. McCullough and The Wellness Company for making a safe product, in our country. I am grateful for them protecting us through the use of proven products and the peace in knowing that I’m taking something that is precisely what it states on the labels. – Jennifer W.
My daughter was diagnosed with uterine cancer and lung nodules that turned out to be cancerous. She started taking ivermectin/mebendazole 2 weeks ago. She had a PET scan last month and her lungs were littered with dime and pea sized nodules from the top to the bottom of her lungs. She had a biopsy on the 14th of April and the Physician had to SEARCH for a nodule big enough to get a sample from, and the ONE that he found was at the bottom of her left lung that he said was only a few centimeters wide…. Thank All of you Doctors on this site for giving us HOPE and HEALING!!! – Helen
Cllick here to order Ivermectin and Mebendazole from The Wellness Company today.
Note: The information provided on this website is intended for informational purposes only and should not be considered medical advice or used as a substitute for professional healthcare guidance. It is your responsibility to comply with all applicable laws, regulations, and guidelines regarding the purchase, possession, and use of prescription medications.
The post 20 Studies Show the Cancer-Fighting Potential of this Low-Cost Drug appeared first on The Gateway Pundit.